treats Osteoarthritis, Psoriasis, and High cholesterol
Interactions with Drugs
Avocado may decrease the effect of "blood thinning" or anti- inflammatory medications. Some examples include aspirin, anticoagulants ("blood thinners") such as warfarin (Coumadin®) or heparin, anti- platelet drugs such as clopidogel (Plavix®), and non- steroidal anti- inflammatory drugs such as ibuprofen (Motrin®, Advil®) or naproxen (Naprosyn®, Aleve®). Avocado may also interact with other types of anti- inflammatories.
Avocado may add to the effects of cholesterol- lowering medications. Patients taking these medications should consult with a qualified healthcare professional, including a pharmacist.
Avocado contains moderate amounts of tyramine and may increase the risk of high blood pressure when taken with monoamine oxidase inhibitors (MAOIs). Examples of MAOI drugs include isocarboxazid (Marplan®), phenelzine (Nardil®), and tranylcypromine (Parnate®). Caution is advised.
Interactions with Herbs and Dietary Supplements
Avocado may reduce the "blood thinning" effect of certain herbs and supplements, such as garlic or Ginkgo biloba. It may also interact with herbs and supplements that have anti- inflammatory effects. Caution is advised.
Avocado contains moderate amounts of tyramine and may increase the risk of high blood pressure when taken with herbs and supplements that have monoamine oxidase inhibitor (MAOI) activity. Caution is advised.
Avocado is rich in beta- sitosterol. Consuming avocado concurrently with other supplements, including beta- sitosterol, could potentially lead to increased side effects.
This information is based on a professional level monograph edited and peer- reviewed by contributors to the Natural Standard Research Collaboration (www.naturalstandard.com): Tracee Rae Abrams, PharmD (University of Rhode Island); Heather Boon, B.Sc.Phm, PhD (University of Toronto); Mary Giles, PharmD (University of Rhode Island); Cathy DeFranco Kirkwood, MPH (MD Anderson Cancer Center); Hope J. Lafferty, AM (Memorial Sloan- Kettering Cancer Center); Adrianne Rogers, MD (Boston University School of Medicine); Anneli Savinainen, MS (MPI); Lisa Scully, PharmD (University of Rhode Island); Erica Rusie, PharmD (Nova Southeastern University); Catherine Ulbricht, PharmD (Massachusetts General Hospital); Wendy Weissner, BA (Natural Standard Research Collaboration); Shannon Welch, PharmD (Northeastern University); Jen Woods, BS (Northeastern University).